Concomitant hypertension in patients with hypertrophic cardiomyopathy shows a greater burden of myocardial fibrosis on ...

Hypertrophic cardiomyopathy (HCM) is a condition that thickens some of the heart’s muscles, making it harder for the heart to pump blood. Hypertrophic cardiomyopathy (HCM) usually affects the ...

Scientists have found that the "sudden" cardiac death condition related to high-profile deaths or major medical episodes of ...

Hypertrophic cardiomyopathy (HCM) is often seen in patients as an autosomal dominant genetic heart disease with a variable clinical course. It is characterized by left ventricular hypertrophy, and ...

What is Hypertrophic Cardiomyopathy (HCM)? Hypertrophic cardiomyopathy (HCM) is a condition that affects the muscle layer of the heart in patients without any underlying heart problems or systemic ...

You can manage the risks of hypertrophic cardiomyopathy (HCM) with treatment and lifestyle changes. Here’s how to make the most of your next medical checkup. HCM is a genetic condition in which the ...

Hypertrophic cardiomyopathy is an underdiagnosed genetic disorder, resulting from mutations in sarcomeric proteins. It has a highly variable clinical presentation, with some individuals remaining ...

Chris Hill remembers his 14-year-old son, Colin, as a boy who loved to run. “I look back at him as a kid, he always loved running,” Hill recalled. “He always loved being fast. That was kind of his ...

LISBON, Portugal — A novel oral drug offers clinically meaningful improvements in exercise capacity in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM) and reduces the burden of ...

Everyone benefits when biopharmaceutical companies create a culture that can gather and apply patient feedback ...

Hypertrophic cardiomyopathy (HCM) is a genetic condition that results in the thickening of the muscle walls in the left ventricle of the heart. In HCM, muscles in the walls of the heart may become ...